By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Ondine Biomedical Inc.

Ondine Biomedical Inc. (OBI.L)

LSE Market Data in GBP, Fundamentals in CAD
£13.50
-£1.00
-6.90%
Last Update: 17 Jul 2025, 12:27
£59.84M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£5.50 - £15.00
52 Week Range

OBI.L Stock Price Chart

Explore Ondine Biomedical Inc. interactive price chart. Choose custom timeframes to analyze OBI.L price movements and trends.

There is nothing to show.

OBI.L Company Profile

Discover essential business fundamentals and corporate details for Ondine Biomedical Inc. (OBI.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

6 Dec 2021

Employees

18.00

CEO

Carolyn M. Cross MBA

Description

Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.

OBI.L Financial Timeline

Browse a chronological timeline of Ondine Biomedical Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 15 May 2025

Earnings released on 30 Sept 2024

Earnings released on 29 Jun 2024

EPS came in at -£0.02, while revenue for the quarter reached £499.76K.

Earnings released on 7 Jun 2024

Earnings released on 28 Feb 2024

Earnings released on 31 Dec 2023

EPS came in at -£0.02, while revenue for the quarter reached £456.75K.

Earnings released on 10 Aug 2023

Earnings released on 30 Jun 2023

EPS came in at -£0.02, while revenue for the quarter reached £257.33K, beating expectations by +0.69%.

Earnings released on 31 Dec 2022

EPS came in at -£0.04, while revenue for the quarter reached £240.14K.

Earnings released on 27 Sept 2022

EPS came in at -£0.03, while revenue for the quarter reached £167.15K.

Earnings released on 30 Jun 2022

EPS came in at -£0.03, while revenue for the quarter reached £158.66K.

OBI.L Stock Performance

Access detailed OBI.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
OBI.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
OBI.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More